CCL2 and coronary artery disorder: In CD14+ monocytes from coronary artery disease (CAD) patients, H3K9me3 and H3K27me3 levels at the MCP-1 promoter are reduced, leading to increased MCP-1 transcription and plasma concentrations (Greissel et al., 2015; Xiao et al., 2018).